NCT07627763 Prospective Dynamic Cohort Study of Phenotypic Profiles in Patients With Chronic Obstructive Pulmonary Disease
| NCT ID | NCT07627763 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Initiatives Bronchopneumopathie Chronique Obstructive (BPCO) |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-05-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective, multicenter, real-world observational cohort study will describe phenotypic profiles, patient characteristics, and treatments in adults with stable chronic obstructive pulmonary disease (COPD). The profiles observed in the current cohort will be compared with those of patients recruited between 2005 and 2018 in the previous COPD-BPCO 1 cohort. Patients will be followed for at least 3 years as part of routine care, with no study-specific visit or treatment.
Eligibility Criteria
Inclusion Criteria: Age 18 years or older. * Stable COPD, defined as no exacerbation requiring treatment during the previous 4 weeks. * Confirmed COPD diagnosis based on post-bronchodilator FEV1/FVC \< 70% Exclusion Criteria: * Main diagnosis of bronchiectasis, asthma, or any other significant respiratory disease. * Patients under legal protection. * Pregnant women.
Contact & Investigator
Nicolas ROCHE
PRINCIPAL INVESTIGATOR
HOPITAL COCHIN
Frequently Asked Questions
Who can join the NCT07627763 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07627763 currently recruiting?
Yes, NCT07627763 is actively recruiting participants. Contact the research team at etudes@clin-experts.fr for enrollment information.
Where is the NCT07627763 trial being conducted?
This trial is being conducted at Bordeaux, France, Lille, France, Lille, France, Nancy, France and 3 additional locations.
Who is sponsoring the NCT07627763 clinical trial?
NCT07627763 is sponsored by Initiatives Bronchopneumopathie Chronique Obstructive (BPCO). The principal investigator is Nicolas ROCHE at HOPITAL COCHIN. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.